Cyclophosphamide

Product NDC
69238-1562
Requested package NDC
69238-1562-1
11-digit product format
692381562
Labeler code
69238
Product ID
69238-1562_7c15d013-bd6e-4c5f-ab63-53e4cc8ca0d4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cyclophosphamide
Dosage form
CAPSULE
Route
ORAL
Labeler
Amneal Pharmaceuticals LLC
Application
ANDA210890
Marketing category
ANDA
Marketing start
2026-11-03
Substance
CYCLOPHOSPHAMIDE
Active strength
50 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210890-001CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE25MGCAPSULE / ORALAB2026-11-02
A210890-002CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE50MGCAPSULE / ORALAB2026-11-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A210890-001AB
A210890-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A210890-001CYCLOPHOSPHAMIDE25MGCAPSULE / ORALAB2026-11-02d4dbc9d85df4…
2026-11-14 07:37:172026-10A210890-002CYCLOPHOSPHAMIDE50MGCAPSULE / ORALAB2026-11-02d4dbc9d85df4…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A210890-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A210890-002AB1d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cyclophosphamide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CYCLOPHOSPHAMIDE50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8N3DW7272PInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1437968Internal RxNorm lookup
1437969Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b75d72ab-861c-4463-884b-d499d306bbd2Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CyclophosphamideCYCLOPHOSPHAMIDEAmneal Pharmaceuticals LLCb75d72ab-861c-4463-884b-d499d306bbd22026-03-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210890
application number: ANDA210890
ndc (package): 69238-1562-1
ndc (product): 69238-1562
ndc11 (package): 69238156201

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
69238-1562-169238156201100 CAPSULE in 1 BOTTLE (69238-1562-1) 100 capsule2026-11-03NoNoCurrent